Operational Challenges of Using Overall Survival as a Primary Endpoint Press CoverageVideo Operational Challenges of Using Overall Survival as a Primary Endpoint In this ACT interview, Certara’s Ananth Kadambi discusses the operational hurdles sponsors face as FDA…Certara2025 年 9 月 22 日
Best Practices in Clinical Pharmacology Gap Analysis Blog 临床药理学差距分析最佳实践 2025 年 9 月 19 日 Submitting your New Drug Application (NDA) to the FDA is the ultimate…Certara2025 年 9 月 19 日
Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC Announcement Certara Announces Fall 2025 Certainty Circuit in EMEA, APAC Join Certara's Fall 2025 Certainty Circuit in EMEA & APAC to explore AI-enabled biosimulation insights,…Certara2025 年 9 月 17 日
What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization? 新闻报导 What are the biggest roadblocks still standing in the way of cell and gene therapy commercialization? Explore the top challenges in cell & gene therapy commercialization, featuring expert insights from Fran…Certara2025 年 9 月 12 日
Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Guide Top 10 Things to Know About ADNCA for Non-Compartmental Analysis Learn how to transition from non-standard ADPC datasets to the CDISC ADNCA ADaM standard. Improve…Certara2025 年 9 月 11 日
TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind On-Demand Webinar TrialAssure & Certara Joint Webinar: Authoring Clinical Documents with Downstream Regulatory Requirements in Mind Watch our on-demand webinar from Certara and TrialAssure to learn how to author clinical documents…Certara2025 年 9 月 10 日
Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research Press Coverage Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research The article, "Move Away From Animal-Only Testing May Improve, Speed Rare Disease Research," explores a…Danielle Pillsbury2025 年 9 月 10 日
AI-driven drug discovery picks up as FDA pushes to reduce animal testing Press Coverage AI-driven drug discovery picks up as FDA pushes to reduce animal testing AI is revolutionizing drug discovery and safety testing as drug developers adopt these technologies in…Certara2025 年 9 月 9 日
Redefining Every Stage of Investment (RESI) Seed to Exit Conference Redefining Every Stage of Investment (RESI) Seed to Exit –Certara2025 年 9 月 5 日
Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Case Study Large Biotech Streamlines Investigator’s Brochures with Certara’s Project Management Expertise Learn how Certara's project management team helped a large biotech streamline the development and updates…Certara2025 年 9 月 5 日